Erythromelalgia of the ears: An unusual variant and response to therapy

Journal of Drugs in Dermatology

Volumn 7, Issue 3, 2008, Pages 285-287

  Berk, David R ^a   Eisen, Arthur Z ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; KETAMINE;

AGED; ARTICLE; CASE REPORT; DRUG COMBINATION; EAR; EAR DISEASE; ERYTHROMELALGIA; FEMALE; GEL; HUMAN; ORAL DRUG ADMINISTRATION; PATHOLOGY; SKIN;

ADMINISTRATION, ORAL; AGED; AMITRIPTYLINE; ANALGESICS; DRUG COMBINATIONS; EAR; EAR DISEASES; ERYTHROMELALGIA; FEMALE; GELS; HUMANS; KETAMINE; SKIN;

EID: 47249085659     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Mork C, Asker CL, Salerud EG, Kvernebo K. Microvascular arteriovenous shunting is a probable pathogenetic mechanism in erythromelalgia. J Invest Dermatol. 2000;114:643-646. (Pubitemid 30226994)
2. Davis MD, Rooke TW, Sandroni P. Mechanisms other than shunting are likely contributing to the pathophysiology of erythromelalgia. J Invest Dermatol. 2000;115:1166-1167. (Pubitemid 32037471)
3. Michiels JJ, te Morsche RH, Jansen JB, Drenth JP. Autosomal dominant erythermelalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7. Arch Neurol. 2005;62:1587-1590. (Pubitemid 41434565)
4. Davis MD, O'Fallon WM, Rogers RS 3rd, Rooke TW. Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol. 2000;136:330-336. (Pubitemid 30149105)
5. Ramirez CC, Kirsner RS. A refractory case of erythromelalgia involving the ears. Am J Otolaryngol. 2004;25:251-254. (Pubitemid 38953662)
6. Sandroni P, Davis MD. Combination gel of 1% amitriptyline and 0.5% ketamine to treat refractory erythromelalgia pain: a new treatment option? Arch Dermatol. 2006;142:283-286.
7. Kalgaard OM, Seem E, Kvernebo K. Erythromelalgia: a clinical study of 87 cases. J Intern Med. 1997;242:191-197. (Pubitemid 27400431)
8. Babb RR, Alarcon-Segovia D, Fairbairn JF 2nd. Erythermalgia. review of 51 cases. Circulation. 1964;29:136-141.
9. Kumar N, Swanson JW. The 'red ear syndrome' revisited: two cases and a review of literature. Cephalalgia. 2004;24:305-308. (Pubitemid 38446173)
10. Rush AM, Dib-Hajj SD, Liu S, et al. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc Natl Acad Sci U S A. 2006;103:8245-8250. (Pubitemid 43801083)
11. Sheets PL, Jackson JO 2nd, Waxman SG, et al. A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity. J Physiol. 2007;581:1019-1031. (Pubitemid 46887978)
12. Han C, Lampert A, Rush AM, et al. Temperature dependence of erythromelalgia mutation L858F in sodium channel Nav1.7. Mol Pain. 2007;3:3.
13. Fertleman CR, Baker MD, Parker KA, et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron. 2006;52:767-774. (Pubitemid 44828442)
14. Goldberg YP, MacFarlane J, MacDonald ML, et al. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet. 2007; 71:311-319. (Pubitemid 46690905)
15. Davis MD, Weenig RH, Genebriera J, et al. Histopathologic findings in primary erythromelalgia are nonspecific: special studies show a decrease in small nerve fiber density. J Am Acad Dermatol. 2006;55:519-522. (Pubitemid 44189596)
16. Drenth JP, Vuzevski V, Van Joost T, et al. Cutaneous pathology in primary erythermalgia. Am J Dermatopathol. 1996;18:30-34. (Pubitemid 26080756)
17. Mork C, Salerud EG, Asker CL, Kvernebo K. The prostaglandin E1 analog misoprostol reduces symptoms and microvascular arteriovenous shunting in erythromelalgia-a double-blind, crossover, placebo-compared study. J Invest Dermatol. 2004;122:587-593. (Pubitemid 38471322)
18. Uchida K, Arita H, Hanaoka K. Successful intravenous administration of low dose ketamine for pain caused by erythromelalgia: report of a case. [In Japanese.] Masui. 2002;51:1248-1250. (Pubitemid 35429030)
19. Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain. 2005;6:644-649. (Pubitemid 41395055)